Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
3(38%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
13%
Ph not_applicable
4
50%
Ph phase_2
1
13%
Ph phase_4
1
13%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
4(57.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(6)
Completed(1)
Terminated(1)

Detailed Status

Not yet recruiting3
Active, not recruiting2
Recruiting1
Withdrawn1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (14.3%)
Phase 21 (14.3%)
Phase 41 (14.3%)
N/A4 (57.1%)

Trials by Status

not_yet_recruiting338%
recruiting113%
withdrawn113%
active_not_recruiting225%
completed113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8